155 related articles for article (PubMed ID: 38520748)
1. Use of testosterone replacement therapy to treat long-COVID-related hypogonadism.
Amodeo A; Persani L; Bonomi M; Cangiano B
Endocrinol Diabetes Metab Case Rep; 2024 Jan; 2024(1):. PubMed ID: 38520748
[TBL] [Abstract][Full Text] [Related]
2. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).
Rosen RC; Wu F; Behre HM; Porst H; Meuleman EJH; Maggi M; Romero-Otero J; Martinez-Salamanca JI; Jones TH; Debruyne FMJ; Kurth KH; Hackett GI; Quinton R; Stroberg P; Reisman Y; Pescatori ES; Morales A; Bassas L; Cruz N; Cunningham GR; Wheaton OA;
J Sex Med; 2017 Sep; 14(9):1104-1115. PubMed ID: 28781213
[TBL] [Abstract][Full Text] [Related]
3. Late-Onset Hypogonadism in a Male Patient with Long COVID Diagnosed by Exclusion of ME/CFS.
Soejima Y; Otsuka Y; Tokumasu K; Nakano Y; Harada K; Nakamoto K; Sunada N; Sakurada Y; Hasegawa K; Hagiya H; Ueda K; Otsuka F
Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454374
[TBL] [Abstract][Full Text] [Related]
4. EMAS position statement: Testosterone replacement therapy in older men.
Kanakis GA; Pofi R; Goulis DG; Isidori AM; Armeni E; Erel CT; Fistonić I; Hillard T; Hirschberg AL; Meczekalski B; Mendoza N; Mueck AO; Simoncini T; Stute P; van Dijken D; Rees M; Lambrinoudaki I
Maturitas; 2023 Dec; 178():107854. PubMed ID: 37845136
[TBL] [Abstract][Full Text] [Related]
5. Patient-reported outcomes and biochemical alterations during hormonal therapy in men with hypogonadotropic hypogonadism who have finished infertility treatment.
Shiraishi K; Ohmi C; Matsuyama H
Endocr J; 2021 Feb; 68(2):221-229. PubMed ID: 33012744
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism.
Tirabassi G; Delli Muti N; Corona G; Maggi M; Balercia G
J Sex Med; 2014 May; 11(5):1302-8. PubMed ID: 24593124
[TBL] [Abstract][Full Text] [Related]
7. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
Sarosdy MF
Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
[TBL] [Abstract][Full Text] [Related]
8. Male pituitary-gonadal axis dysfunction in post-acute COVID-19 syndrome-Prevalence and associated factors: A Mediterranean case series.
Moreno-Perez O; Merino E; Alfayate R; Torregrosa ME; Andres M; Leon-Ramirez JM; Boix V; Gil J; Pico A;
Clin Endocrinol (Oxf); 2022 Mar; 96(3):353-362. PubMed ID: 34160836
[TBL] [Abstract][Full Text] [Related]
9. Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.
Giagulli VA; Carbone MD; Ramunni MI; Licchelli B; De Pergola G; Sabbà C; Guastamacchia E; Triggiani V
Andrology; 2015 Nov; 3(6):1094-103. PubMed ID: 26447645
[TBL] [Abstract][Full Text] [Related]
10. Testosterone replacement in congenital hypogonadotropic hypogonadism maintains bone density but has only limited osteoanabolic effects.
Antonio L; Caerels S; Jardi F; Delaunay E; Vanderschueren D
Andrology; 2019 May; 7(3):302-306. PubMed ID: 30851011
[TBL] [Abstract][Full Text] [Related]
11. Central body fat changes in men affected by post-surgical hypogonadotropic hypogonadism undergoing testosterone replacement therapy are modulated by androgen receptor CAG polymorphism.
Tirabassi G; delli Muti N; Buldreghini E; Lenzi A; Balercia G
Nutr Metab Cardiovasc Dis; 2014 Aug; 24(8):908-13. PubMed ID: 24787905
[TBL] [Abstract][Full Text] [Related]
12. Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: focus on the role of androgen receptor CAG polymorphism.
Tirabassi G; delli Muti N; Gioia A; Biagioli A; Lenzi A; Balercia G
J Endocrinol Invest; 2014 Apr; 37(4):393-400. PubMed ID: 24458833
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 Infection in Men on Testosterone Replacement Therapy.
Rambhatla A; Bronkema CJ; Corsi N; Keeley J; Sood A; Affas Z; Dabaja AA; Rogers CG; Liroff SA; Abdollah F
J Sex Med; 2021 Jan; 18(1):215-218. PubMed ID: 33191186
[TBL] [Abstract][Full Text] [Related]
14. Coexistence of growth hormone, adrenocorticotropic hormone, and testosterone deficiency associated with coronavirus disease 2019: a case followed up for 15 months.
Yoshimura K; Yamamoto M; Inoue T; Fukuoka H; Iida K; Ogawa W
Endocr J; 2022 Nov; 69(11):1335-1342. PubMed ID: 35831125
[TBL] [Abstract][Full Text] [Related]
15. Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men.
Borst SE; Yarrow JF
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1035-42. PubMed ID: 25898953
[TBL] [Abstract][Full Text] [Related]
16. Testosterone Therapy and Its Monitoring in Adolescent Boys with Hypogonadism: Results of an International Survey from the I-DSD Registry.
Stancampiano MR; Lucas-Herald AK; Bryce J; Russo G; Barera G; Balsamo A; Baronio F; Bertelloni S; Valiani M; Cools M; Tack LJW; Darendeliler F; Poyrazoglu S; Globa E; Grinspon R; Hannema SE; Hughes IA; Tadokoro-Cuccaro R; Thankamony A; Iotova V; Mladenov V; Konrad D; Mazen I; Niedziela M; Kolesinska Z; Nordenström A; Ahmed SF
Sex Dev; 2021; 15(4):236-243. PubMed ID: 34350903
[TBL] [Abstract][Full Text] [Related]
17. Improved Lower Urinary Tract Symptoms Associated With Testosterone Replacement Therapy in Japanese Men With Late-Onset Hypogonadism.
Okada K; Miyake H; Ishida T; Sumii K; Enatsu N; Chiba K; Matsushita K; Fujisawa M
Am J Mens Health; 2018 Sep; 12(5):1403-1408. PubMed ID: 27256990
[TBL] [Abstract][Full Text] [Related]
18. Effects of testosterone replacement therapy on nocturia and quality of life in men with hypogonadism: a subanalysis of a previous prospective randomized controlled study in Japan.
Shigehara K; Konaka H; Koh E; Izumi K; Kitagawa Y; Mizokami A; Nakashima T; Shimamura M; Iwamoto T; Namiki M
Aging Male; 2015; 18(3):169-74. PubMed ID: 26075538
[TBL] [Abstract][Full Text] [Related]
19. Testosterone Therapy: What We Have Learned From Trials.
Corona G; Torres LO; Maggi M
J Sex Med; 2020 Mar; 17(3):447-460. PubMed ID: 31928918
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
